The Environmental Health Association Ireland (EHAI) has awarded the John Shelly Bursary to the ISF, in support of our work to raise awareness about the
The International Alliance for Dermatology Patient Organizations (also known as GlobalSkin) in collaboration with researchers at Cardiff University (UK) and University Medical Centre Hamburg-Eppendorf (Germany)
The ISF offers trusted support through our Ask-a-Nurse Helpline and in our videos, booklets, social media posts, and website articles. It is important that our
Do women get psoriasis earlier than men? UK researchers performed a review of published studies on the number of new individuals affected by psoriasis during
The GRIDD project is the first global patient-initiated and patient-led impact research study in dermatology. Global Research on the Impact of Dermatological Diseases (GRIDD) was launched
The SECURE-AD patient survey is adapting to include the question, ‘How does the COVID-19 vaccination affect patients with eczema?’ In 2020, the SECURE-AD Patient survey
In November and December of 2020, the Global Coalition for Melanoma Patient Advocacy, conducted a survey of 734 dermatologists from 36 different countries. In the survey,
BIOMAP have released a short animation which aims to demonstrate BIOMAP’s project work to alleviate the burden and consequences of AD and psoriasis for people
Are you aged 18-65 and living with psoriasis, eczema or ichthyosis vulgaris? You may be eligible to participate in a study to investigate the role
This study is now closed. The University College Dublin (UCD) School of Psychology, in collaboration with the Dún Laoghaire-Rathdown Children’s and Young Peoples’ Services Committee
The GRIDD project is the first global patient-initiated and patient-led impact research study in dermatology. Global Research on the Impact of Dermatological Diseases (GRIDD) was
A nationwide campaign launched by the Irish Platform for Patients’ Organisations, Science & Industry (IPPOSI) will identify 25 members of the public, broadly representative of
Globally, 21 atopic dermatitis patient organisations have become official partners of SECURE-AD, two international COVID-19 surveys for atopic dermatitis (also known as AD or eczema)
The Irish Skin Foundation are delighted to collaborate with the International Federation of Psoriasis Associations (IFPA) and Novartis on the launch of Psoriasis and Beyond:
A new report titled, Children’s exposure to ultraviolet radiation – a risk profile for future skin cancers in Ireland, which was published on June 17th
The Irish Skin Foundation is delighted to be a partner of SECURE-AD, two international COVID-registries for atopic dermatitis/eczema. One registry, is completed by healthcare providers
The International Alliance of Dermatology Patient Organisations (IADPO) also known as Global Skin, of which the ISF is a founding member, convened a webinar titled:
PsoProtectMe is a new initiative by PsoProtect for psoriasis patients to self-report their COVID-19 experience. The Irish Skin Foundation is delighted to be a partner
Dr Alan Maddock, lecturer at Queen’s University Belfast, discusses ‘The impact of Mindfulness-Based Cognitive Therapy on Psoriasis’. According to new data released by the Global
ISF joins efforts to support a new international initiative, specific to psoriasis, has been set up as response to the COVID-19 pandemic PsoProtect is an
Irish Skin Foundation, Charles Institute of Dermatology, University College Dublin, Dublin D04 V1W8, Ireland.
tel: (01) 486 6280 | e-mail: info@irishskin.ie | www.irishskin.ie
Registered Charity Number: 20078706